Clinical Trials · NCT00781937
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 422
- Start date
- Oct 2008
- Locations
- 37 sites, United States, Canada
- Primary endpoint
- Mean Percentage Change in Fasting Body Weight From Baseline